EGFR and non-small cell lung carcinoma: This approach was also applied for the development of a clinical test developed by Exosomes Diagnostics (ExoDx Lung(EGFR T790M)), which efficiently identified different EGFR mutations (L858R, T790M, and exon 19 indels) in plasma sEVs from a large cohort of non-small cell lung carcinoma (NSCLC) patients [112].